FREE Account Opening + No Clearing Fees
Loading...
September 9, 2008 - September 12, 2008

Chemcel Biotech IPO Latest News Today

Track all the latest updates and news of Chemcel Biotech IPO.

  1. Why This Hot Biotech IPO Might Just Be a Winning Bet

    March 15, 2024 9:37:00 AM

    While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.

    Published by : The UBJ on MSN
  2. Why That Hot Biotech IPO Could Be a Winner

    March 14, 2024 2:33:00 PM

    with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...

    Published by : MSN
  3. Chemcel Biotech Financials Statement

    February 25, 2024 1:24:00 AM

    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.

    Published by : India Infoline
  4. Boundless Bio bumps IPO market back to life after sleepy few weeks

    March 6, 2024 7:50:00 PM

    Just when it seemed like the biotech IPOs were being lulled back to sleep, Boundless Bio says it plans to hit Wall Street. The Arch-, Bayer- and RA-backed company filed an S-1 Wednesday afternoon ...

    Published by : FierceBiotech
  5. Biotech IPOs heated up to start 2024. Will the surge last?

    March 5, 2024 2:30:00 AM

    Those IPOs, combined with the recovery of biotech�s two flagship stock funds and a dealmaking surge, have given industry watchers reasons to be optimistic. �Some of the trends that are going ...

    Published by : Yahoo Finance
  6. Biotech IPO market heats up as BioHavens debut impresses

    May 5, 2017 3:30:00 AM

    The biotech IPO market seems to be heating up after three stock market launches in quick succession, including the largest launch seen in the sector this year. After a boom in 2014 and 2015 ...

    Published by : pharmaphorum
  7. IPO Preview: Legend Biotech Seeks U.S. IPO

    May 19, 2020 3:30:00 AM

    Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...

    Published by : TheStreet.com
  8. Acelyrin raises $540 million in rare biotech IPO

    May 5, 2023 3:30:00 AM

    The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...

    Published by : pharmaphorum
  9. Why That Hot Biotech IPO Could Be a Winner

    March 14, 2024 3:30:00 PM

    The best time to make money in biotech is usually during periods of cautious optimism. There are strong signs that right now might be one of those moments. The always-volatile industry has just ...

    Published by : Wall Street Journal
  10. Why That Hot Biotech IPO Could Be a Winner

    March 15, 2024 6:19:00 AM

    Biotechnology IPOs tend to do well over the long term just as financing markets begin to thaw, an analysis shows. The best time to make money in biotech is usually during periods of cautious optimism.

    Published by : Mint

Chemcel Biotech IPO Alerts

1. Chemcel IPO stocks listed at 67.50% discount  Monday, October 13, 2008 10:23:06 AM

Chemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.

Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.

Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.

2. Chemcel Biotech Limited IPO - Listing  Monday, October 13, 2008 12:00:00 AM

Chemcel Biotech IPO Listing Date & Info:

IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share

3. Chemcel Biotech IPO Listing Information  Wednesday, October 8, 2008 7:23:18 AM

Chemcel Biotech IPO Listing Date & Info:

IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share

4. Chemcel Biotech IPO Allotment Status  Friday, October 3, 2008 8:22:24 AM

IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.

Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.

 

5. Chemcel Biotech Limited IPO - Allotment  Friday, October 3, 2008 12:00:00 AM

IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.

Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.

6. Chemcel Biotech Limited IPO - Close  Friday, September 12, 2008 12:00:00 AM

Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company�s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.

Chemcel Biotech Limited is entering in the capital markets with a fixed price initial public offering, IPO of 1,54,00,000 Equity Shares for cash, at a premium of Rs 6/-.

The price band for the issue has been fixed at Rs. 16/- for equity share of Rs. 10/-. The issue opens on September 09, 2008 and closes for subscription on September 12, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

7. Chemcel Biotech Limited IPO - Open  Tuesday, September 9, 2008 12:00:00 AM

Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company�s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.

Chemcel Biotech Limited is entering in the capital markets with a fixed price initial public offering, IPO of 1,54,00,000 Equity Shares for cash, at a premium of Rs 6/-.

The price band for the issue has been fixed at Rs. 16/- for equity share of Rs. 10/-. The issue opens on September 09, 2008 and closes for subscription on September 12, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).

Chemcel Biotech IPO News & Events FAQs

The Chemcel Biotech IPO is proposed to open on September 9, 2008. The IPO application ends on September 12, 2008.

Retail investors can apply in the retail or non-institutional investor category from September 9, 2008 to September 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Chemcel Biotech IPO will open for subscription on September 9, 2008. The public issue will close on September 12, 2008.